boston-healthtech
(7)
Neuroglee Health
Neuroglee Health is a Boston-based digital health company building value-based, at-home dementia and cognitive care. It pairs a virtual interdisciplinary clinical team - advanced practice nurses, social workers, pharmacists and care navigators supervised by neurologists and geriatric psychiatrists - with evidence-based digital therapeutics to support patients with mild cognitive impairment through late-stage dementia and their care partners. Founded in 2020 by Aniket Singh Rajput, the company works with Mayo Clinic on its Neuroglee Connect platform and participates in the CMS GUIDE Model to deliver comprehensive, longitudinal dementia care to Medicare beneficiaries at no cost to families.
Scripta Insights
Scripta Insights is a Needham, Massachusetts healthcare technology company that helps self-insured employers, health plans and their members cut pharmacy benefit costs without switching PBMs. Its Rx Navigation platform, powered by the proprietary Med Mapper AI engine, analyzes prescription claims and clinical data to surface lower-cost, therapeutically equivalent medication options - getting patients 'The Right Meds at The Best Price.' Founded in 2019 by serial entrepreneur Eric Levin and physician Dr. Paul Bradley, the company serves more than 80 employer and health-plan clients and raised $42M total after a $17M Series B in December 2024.
Malachi Charbonneau
Malachi Charbonneau is the general manager and chief executive of medaptus, a Boston-based healthcare software company that automates charge capture, revenue integrity and hospitalist patient assignment. He joined medaptus in 2011 and worked his way up through implementation, customer care, and sales before taking the top job in 2021, giving him a rare, ground-level view of how hospitals actually run their revenue cycles and staff their care teams. Under his leadership medaptus, now a Volaris Group business, has expanded its Charge Pro and Assign products and partnered with large health systems such as Banner Health.
Matthew Levesque
Matthew Levesque is chief executive of IntelyCare, the Quincy, Massachusetts nurse-staffing platform that pairs per-diem shifts with roughly a million registered nursing professionals. He arrived in July 2024 after running Groups Recover Together and, before that, connectRN, and before that spending twelve years at athenahealth as it grew from a hundred-million-dollar company to a $1.3 billion one. In December 2025 he engineered IntelyCare's acquisition of CareRev, combining two of the loudest names in shift-based nurse labor into a single platform for hospitals and post-acute facilities.
PrescriberPoint
PrescriberPoint is a Boston-based, AI-enabled point-of-care platform that supports clinicians at every step of the prescribing journey - from researching FDA-approved drug information to checking coverage and out-of-pocket costs, submitting prior authorizations, and enrolling patients in savings programs. Spun out of work with Eli Lilly and BCG, it consolidates fragmented prescribing resources for tens of thousands of medications into one portal, and in 2025 reached more than 5 million healthcare professionals - one of the largest active HCP networks in digital health.
Dan Rubin
Dan Rubin is President and CEO of PARx Solutions, a Burlington, Massachusetts healthtech company that runs the Prior Authorization Support System (PASS), a service that helps physician offices push prescriptions past insurer prior-authorization roadblocks at no cost to the practice. A chemical engineer by training who switched to building businesses, Rubin co-founded medication-adherence pioneer Adheris in 1993, ran it for fifteen years, then took the helm at PARx in 2012. He has spent three decades on a single problem: the gap between a doctor writing a prescription and a patient actually getting the medicine.
Diagnostic Robotics
Diagnostic Robotics is an AI healthcare company building medical-grade triage and clinical-prediction software for health plans and providers. Its models, trained on tens of billions of claims data points and nearly 100 million patient visits, forecast avoidable ER visits, congestive heart failure deterioration and serious mental illness, then steer patients into the right care pathway. Founded in 2017 by Kira Radinsky, Jonathan (Yonatan) Amir and Moshe Shoham, the company is a Mayo Clinic Platform portfolio company and closed a $45M Series B in 2022.